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Abstract
Background: Osteoarthritis is a multifactorial disease characterized by destruction of the articular cartilage due to genetic,
mechanical and environmental components affecting more than 100 million individuals all over the world. Despite the high
prevalence of the disease, the absence of large-scale molecular studies limits our ability to understand the molecular
pathobiology of osteoathritis and identify targets for drug development.
Methodology/Principal Findings: In this study we integrated genetic, bioinformatic and proteomic approaches in order to
identify new genes and their collaborative networks involved in osteoarthritis pathogenesis. MicroRNA profiling of patient-
derived osteoarthritic cartilage in comparison to normal cartilage, revealed a 16 microRNA osteoarthritis gene signature.
Using reverse-phase protein arrays in the same tissues we detected 76 differentially expressed proteins between
osteoarthritic and normal chondrocytes. Proteins such as SOX11, FGF23, KLF6, WWOX and GDF15 not implicated previously
in the genesis of osteoarthritis were identified. Integration of microRNA and proteomic data with microRNA gene-target
prediction algorithms, generated a potential ‘‘interactome’’ network consisting of 11 microRNAs and 58 proteins linked by
414 potential functional associations. Comparison of the molecular and clinical data, revealed specific microRNAs (miR-22,
miR-103) and proteins (PPARA, BMP7, IL1B) to be highly correlated with Body Mass Index (BMI). Experimental validation
revealed that miR-22 regulated PPARA and BMP7 expression and its inhibition blocked inflammatory and catabolic changes
in osteoarthritic chondrocytes.
Conclusions/Significance: Our findings indicate that obesity and inflammation are related to osteoarthritis, a metabolic
disease affected by microRNA deregulation. Gene network approaches provide new insights for elucidating the complexity
of diseases such as osteoarthritis. The integration of microRNA, proteomic and clinical data provides a detailed picture of
how a network state is correlated with disease and furthermore leads to the development of new treatments. This strategy
will help to improve the understanding of the pathogenesis of multifactorial diseases such as osteoarthritis and provide
possible novel therapeutic targets.
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Introduction
Osteoarthritis is a multifactorial disease characterized by
destruction of the articular cartilage due to genetic, mechanical
and environmental components [1], affecting more than 20
million people in the US [2]. Despite its high prevalence there are
few studies concerning the molecular pathobiology and the
involvement of genetic factors in the pathogenesis of osteoarthritis
[3,4]. Several clinical studies have implicated the causative role of
obesity in osteoarthritis development [5,6], however there are few
molecular studies correlating metabolism with osteoarthritis [7,8].
Achieving a deeper understanding of osteoarthritis molecular
mechanisms requires global strategies aimed at modelling the
functional interrelationships between genes as complex interde-
pendent networks.
Lately, it has become evident that genetic alterations in non-
coding genes can also contribute to the pathogenesis of human
disease [9]. A new class of small non-coding RNAs, named
microRNAs, regulate gene expression by inhibition of translation
or mRNA cleavage [10]. MicroRNAs have been implicated in
important cellular processes such as lipid metabolism [11],
apoptosis [12], differentiation [13] and organ development [14].
Furthermore microRNAs expression signatures have been associ-
ated with well-defined clinicopathological features and disease
outcome [15]. It is known that microRNAs exert their biological
functions through suppression of their target genes. Several
PLoS ONE | www.plosone.org 1 November 2008 | Volume 3 | Issue 11 | e3740bioinformatic algorithms have been constructed in order to predict
microRNA gene targets. Most of these algorithms search for
sequence complementarity between the microRNA and the 39
UTR of the gene target. These algorithms predict hundreds of
potential gene targets, which can not all be experimentally
validated. Previous studies have tried to identify microRNA gene
targets using cDNA microarray data [16]. However, it has been
shown that a microRNA (miR-10b) regulates gene expression only
at the protein level, while mRNA levels were not affected [17]. In
addition, very recently Selbach et al, showed that a microRNA can
repress the production of hundred of proteins [18]. Therefore, it
becomes evident that proteomic data are needed in order to
accurately detect microRNA gene targets. Up to now there are few
studies trying to characterize the cartilage proteome. More
specifically, recently Vincourt et al, performed a detailed two
dimensional electrophoresis-based proteomic analysis of articular
cartilage [19]. In addition Wu et al. performed a comparative
proteomic analysis of cartilage from healthy donors and
osteoarthritis patients, however the number of samples used was
very small [20].
For all above reasons, we undertook to associate specific
microRNAs and proteins with the development of osteoarthritis
and clinicopathological parameters, in order to identify new
signalling pathways involved in its pathogenesis. Here, we report a
novel approach of studying multi-aetiological diseases and
identifying new genes involved in the pathogenesis of a complex
disease. Integration of microRNA microarray and proteomic
analysis data together with computational approaches, such as
microRNA gene target prediction algorithms and gene network
construction, revealed the role of microRNAs in cartilage
destruction and linked inflammatory and metabolic gene networks
with cartilage homeostasis.
Materials and Methods
Cartilage tissue samples
Articular cartilage samples were obtained from femoral heads,
femoral condyles and tibial plateaus of patients with primary
osteoarthritis undergoing hip or knee replacement surgery at the
Orthopaedics Department of University Hospital of Larissa. A
total of 33 patients were included in this study (twenty eight
females and five males; mean age 68.9166.97 years, range 57–83;
mean Body Mass Index (BMI) 30.5165.23, range 22.67–43.96)
who had undergone total knee replacement surgery. Each sample
was categorized according to its gross morphology, as severely
damaged and was taken from the main defective area of maximal
load. Macroscopic findings were validated by histological studies
performed on 5 mm serial sections of cartilage samples and graded
using the Mankin score. Specimens with osteoarthritis had Mankin
score 10–14. Normal cartilage was obtained from small free
cartilaginous fragments from ten individuals (six females and four
males; mean age 61.70618.17, range 27–78; mean BMI
23.8064.34, range 19.03–35.06) with 0 Mankin score, undergoing
fracture repair surgery, with no history of joint disease. Both
patients and healthy individual’s cartilage samples were obtained
upon individuals’ verbal informed consent. The method of
obtaining verbal approval by all individuals was approved by
Institutional Review Board of the University Hospital of Larissa.
Also the protocol was approved by the local ethics committee of
University Hospital of Larissa.
Detection of microRNA expression
Expression levels of 365 microRNAs were evaluated with
TaqMan microRNA microarray assays as previously described
[21]. Validation of these results was performed using the mirVana
qRT–PCR miRNA Detection Kit and qRT–PCR Primer Sets,
according to the manufacturer’s instructions (Ambion Inc, TX,
USA). The U6 small nuclear RNA was used as an internal control.
MicroRNA Northern Blot Analysis
For microRNA Northern Blot Analysis, 10ug of RNA were
separated on 12% denaturating polyacrylamide gels and trans-
ferred to GeneScreen Plus membrane (PerkinElmer, Waltham).
MiRCURY LNA Probes for miR-483 and miR-22 (Exiqon,
Denmark) were end-labeled with T4 polynucleotide kinase.
Prehybridization of the filters was carried out in 50% formamide,
0.5% SDS, 5? SSPE, 5?Denhardt’s solution and 20 mg/ml
sheared, denatured salmon sperm DNA. Hybridizations were
performed in the same solution at 42uC. The labeled probes were
heated for 1 min at 95uC before addition to the filters in the
prehybridization solution. After hybridization, the membranes
were washed in 0.1 SSC, 0.1% SDS at 42uC twice for 10 min.
Reverse-Phase protein microarray analysis
Chondrocyte cell lysates were boiled for 5 min and were loaded
into 384-well plates in serial dilutions (neat, 1:2, 1:4, 1:8, and 1:16)
with negative control wells containing only lysis buffer. These
samples were printed in duplicate onto nitrocellulose-coated glass
slides (Schleicher & Schuell Bioscience, Keene, NH) using a ring-
and-pin robotic arrayer (GMS 417, Affymetrix, Santa Clara, CA).
The arrays were stained as previously described [22] on an
autostainer (DAKO, Carpinteria, CA) using a biotinyl-linked
catalyzed signal amplification system (DAKO). Specificity of each
antibody was tested by western blot analysis.
Statistical analysis
All calculations were performed on a Microsoft computer, using
the SPSS software (version 12.0). Correlation of between
microRNA and protein expression levels with BMI was identified
by correlation coefficients, calculated by Pearson rank correlation
(r) and Spearman rank correlation. Statistical methods regarding
the proteomic analysis are described analytically in the suppl.
Methods section. Construction and statistical significance of gene
networks was performed by Ingenuity pathway analysis. Statistical
significant networks were considered those with p value higher
than 10
25. In addition clustering of the protein data in functional
groups was performed using DAVID NIH Bioinformatics
Database with a p value cut-off of 10
25. Quantification of western
blots was performed by standard densitometric analysis. All
transfection experiments were performed in triplicate and the
results were compared by student’s t-test analysis.
Additional methods
Detailed experimental methods are described in the supple-
mental methods section (Methods S1).
Results
MicroRNA gene signature of osteoarthritis
To identify microRNAs involved in osteoarthritis, we tested the
expression of 365 microRNAs in articular cartilage obtained from
patients with osteoarthritis undergoing knee replacement surgery
and from normal individuals with no history of joint disease. We
identified 16 microRNAs differentially expressed in osteoarthritic
compared to normal cartilage (Figure 1A). Specifically we
detected nine up-regulated and seven down-regulated microRNAs
in osteoarthritic cartilage compared to normal (Table S1). Real-
time PCR and Northern blot analysis (Figure 1B, C; Table S2)
Networks in Osteoarthritis
PLoS ONE | www.plosone.org 2 November 2008 | Volume 3 | Issue 11 | e3740validated that this 16 microRNA gene signature was able to
distinguish osteoarthritic from normal chondrocytes.
microRNA expression correlates with BMI
Clinical characteristics of the patients and normal individuals
(Table 1) allowed us to study potential correlations between
microRNAs expression and clinicopathological parameters. Very
interestingly, we found five microRNAs to be statistically
correlated with body mass index (BMI) (Figure 1C). miR-22
and miR-103 expression was positively correlated with BMI, while
miR-25, miR-337 and miR-29a expression was inversely corre-
lated, pointing towards the potential role of microRNAs in lipid
metabolism and osteoarthritis pathogenesis.
Proteomic analysis of articular cartilage
In order to identify deregulated proteins in osteoarthritic
chondrocytes and study in detail whether obesity and osteoarthritis
are correlated at a molecular level, we performed proteomic analysis
in the same articular cartilage samples that we performed
microRNA expression analysis. Specifically reverse-phase protein
arrays were constructed [23] (Figure S1A) and probed with
antibodies to 214 proteins expressed in articular cartilage (Table
S3). All antibodies were tested for their quality and specificity by
Western blot analysis (Figure S1B) Arrays were scanned and
dilution curves were used to quantify relative protein expression
(Figure S1C). We detected that 76 proteins, (48 up-regulated and
28 down-regulated) were differentially expressed between osteoar-
thritic and normal chondrocytes (Figure 2A). These results were
validated by western blot analysis (Figure 2B). We were able to
identify for the first time deregulated proteins in osteoarthritic
chondrocytes that were implicated in inflammatory and lipid
metabolism pathways. More specifically, we detected up-regulation
of proteins involved in inflammatory pathways such as IL1B, IL6
and CCR3, while proteins (PPARA, PPARG, ACOX1) involved in
lipid metabolism mechanisms, were found highly down-regulated in
osteoarthritic chondrocytes (Figure 2A, B). In addition we detected
novel proteins that were deregulated in osteoarthritis, such as
SOX11, FGF23, KLF6, WWOX and GDF15.
Around half of the deregulated proteins in osteoarthritic
chondrocytes were located in the extracellular space (50.67%),
Figure 1. MicroRNA gene signature in osteoarthritis and correlation with clinicopathological parameters. (A) Up-regulated (red color)
and down-regulated (green color) microRNAs in 33 osteoarthritic and 10 normal cartilage samples assayed by TaqMan microRNAs assays. Included
microRNAs were more than 2-fold deregulated. (B) Validation of previous results using Real-time SYBR Green microRNA detection assay. (C) Northern
blot validation of microRNA microarray data. Representative examples of miR-483 and miR-22 expression in normal and osteoarthritic cartilage tissues
(OA2, OA17, OA9). (D) MicroRNAs correlated with BMI (Body Mass Index) analyzed by SSPS version 12.0 statistical program.
doi:10.1371/journal.pone.0003740.g001
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and nuclear (13.33%) localization (Figure 2C). Functional
clustering analysis categorized the differentially expressed proteins
in nine statistically significant pathways. Specifically, 45.33% of
the deregulated proteins were involved in cartilage homeostasis
pathways (Figure 2D), while 18.67% and 9.33% were involved in
lipid metabolism and inflammation pathways, respectively.
Metabolism-related proteins correlate with BMI
Furthermore, we tried to correlate the expression levels of
differentially expressed proteins in osteoarthritic cartilage with
clinicopathological parameters, such as Body Mass Index. A recent
study suggested that BMI is a significant risk factor for knee
osteoarthritis leading to arthroplasty, speculating that biomechan-
ics and metabolic factors associated with adipose tissue contribute
to this phenotype [5]. We identified that PPARA, BMP7, IL1B,
LEP, ITGA5 and SREBP1 protein levels in osteoarthritic
chondrocytes were highly correlated with BMI (Figure 2E),
suggesting the potential role of metabolic-related proteins in the
development of osteoarthritis.
Detection of microRNA gene targets
Since microRNAs exert their biological functions through
suppression of target genes, it is important to identify micro-
RNA-target pairs. As the available bioinformatic algorithms
predict hundreds of microRNA-gene target pairs, it is evident
that experimental data are needed for verification of these pairs.
However, as it is known that several microRNAs target gene
expression only at the protein and not at the mRNA level, the
integration of microRNA along with protein data sets could be
considered more effective for microRNA-gene target verification.
Recently Huang et al., used microRNA with cDNA expression
profiling data to identify human microRNA targets using Bayesian
data analysis algorithm [16]. In our study, we identified
microRNA-gene target pairs by matching microRNA and protein
data. Subsequently, we filtered these data through three different
selection criteria (Figure S2) and revealed 17 microRNA-gene
target pairs implicated in osteoarthritis pathogenesis (Table S4).
More specifically, we found microRNA-gene target pairs poten-
tially involved in cartilage homeostasis and structure (miR-377-
CART1, miR-140-ADAMTS5, miR-483-ACAN, miR-23b-
CRTAP, miR-16-TPM2, miR-223-GDF5, miR-509-SOX9,
miR-26a-ASPN), in biomechanic pathways (miR-25-ITGA5), in
apoptotic mechanisms (miR-373-CASP6, miR-210-CASP10) and
in lipid metabolism pathways (miR-22-PPARA, miR-22-BMP7,
miR-103-ACOX1, miR-337-RETN, miR-29a-LEP). Several of
these target genes such as ADAMTS5, GDF5 and LEP have been
previously correlated with osteoarthritis [3,24,25].
Gene networks in osteoarthritis
It is becoming increasingly clear that most proteins interact in
complex cellular networks, the properties of which might be
altered in osteoarthritic compared to normal chondrocytes.
Therefore, global strategies aimed at modeling the functional
interrelationships between microRNA and proteins, as complex
interdependent networks, are required. We integrated microRNA
and protein data sets in order to generate a model of
macromolecular network that is perturbed in osteoarthritis using
Ingenuity program analysis [26]. The resulting network contained
11 microRNAs, 58 proteins and 414 potential functional
associations (Figure 3A). We were able to detect three sub-
networks representing key functional units that make up the co-
expression network. A metabolism-related, an inflammation and a
cartilage homeostasis sub-network were found to be interrelated
contributing all together to cartilage destruction and osteoarthritis
development (Figure S3).
miR-22 correlates with PPARA and BMP7 protein
expression
The functional significance of our predicted ‘‘interactome’’
network was tested by experimental validation. Our finding that
specific microRNAs and proteins were related to BMI, focused our
interest in identifying functional microRNA-gene target pairs
relating obesity with osteoarthritis pathogenesis mechanisms.
Epidemiological studies have shown that the risk for knee
osteoarthritis is increased by 36% for every 2 units of BMI (5
kg) of weight gain [27]. At first we tried to identify which
microRNA-gene target interactions have biological significance
(inverse correlation in expression levels) in our network. According
to our previous combined in silico and expression data analysis we
identified 5 microRNAs (miR-22, miR-103, miR-337, miR-25,
miR-29a) and their 6 targets (PPARA, BMP7, ACOX1, RETN,
ITGA5, LEP) that were highly correlated with BMI (Figure 1C,
Figure 2E). Correlation of microRNA-gene target expression
levels revealed that miR-22 was highly inversely correlated with
PPARA (r
2=0.919) and BMP7 (r
2=0.816). (Figure 3B), while we
detected low correlation between miR-29a with LEP (r
2=0.491),
miR-25 and ITGA5 (r
2=0.456), miR-337 and RETN (r
2=0.385)
and miR-103 and ACOX1 (r
2=0.252). The above results
suggested the potential functional relationship between miR-22,
PPARA and BMP7.
miR-22 regulates PPARA and BMP7 in normal and
osteoarthritic chondrocytes
In order to detect whether PPARA and BMP7 were direct
targets of miR-22, we performed luciferase assay. We found that
BMP7-encoded mRNA contains a 39UTR element that is partially
complementary to miR-22 (Figure 3C) and luciferase assay
showed that BMP-7 is a direct target of miR-22 (69% reduction,
p,0.001, Figure S4A). Furthermore, miR-22 overexpression in
chondrocytes reduced the activity of a luciferase reporter gene
Table 1. Clinicopathological characteristics of osteoarthritis
patients and normal individuals
OA Normal
Characteristic
Female Sex – no (%) 28 (84.8%) 6 (60%)
Age at diagnosis -yr
Median 68.9166.97 61.70618.17
Range 57–83 27–78
Body Mass Index (BMI)
Median 30.5165.23 23.8064.34
Range 22.67–43.96 19.03–35.06
Normal 4 6
Overweight 11 2
Obese 18 2
Kellgrene-Lawrence
Median 3.7260.51 0
Range 2–4 0
doi:10.1371/journal.pone.0003740.t001
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S4B). Evaluation of BMP7 and PPARA mRNA expression levels
after miR-22 expression revealed that only BMP7 mRNA levels
were significantly down-regulated (p,0.001), while PPARA were
not (p=0.492) (Figure S5). Western blot analysis revealed that
miR-22 regulates both PPARA and BMP7 protein expression
levels in normal and osteoarthritic chondrocytes (Figure 3D).
Overexpression of miR-22 inhibited BMP-7 (76%) and PPARA
(93%) protein expression in normal chondrocytes. Subsequently,
inhibition of miR-22 in osteoarthritic chondrocytes by antisense
miR-22 treatment, highly up-regulated BMP-7 (8.35 fold) and
PPARA (12.55 fold) expression, suggesting that miR-22 is a strong
regulator of BMP-7 and PPARA proteins. All above data suggest
that miR-22 regulates BMP-7 at the mRNA level and PPARA at
the protein level, revealing thus the advantage of using proteomic
instead of cDNA microarray data for detecting microRNA gene
targets.
Metabolic, inflammatory and cartilage homeostasis
networks are inter-related
Subsequently, we proceeded by investigating how these miR-22
targetgenepairsarecorrelatedwiththerestoftheproteinspresentin
the ‘‘interactome’’ network. Specifically, PPARA belongs to the
metabolism sub-network, which is connected with the inflammation
sub-networkthrough IL1B.A recent reportsuggested thatPPARAis
a receptor involved in inflammatory processes [28] and was recently
found down-regulated in osteoarthritic cartilage [29]. In our study,
the inflammatory sub-networkhavingIL1B and IL6ascentral nodes
is connected with MMP13, which is central node of the cartilage
structure sub-network. To test this hypothesis predicted by the gene
network of IL1B-MMP13 interaction, we treated normal and
osteoarthritic chondrocytes with IL1B and examined MMP13
expression. We found that IL1B up-regulated MMP13 expression
both at mRNA and protein levels (Figure 4A, B), verifying the
correlation that we had previously described between IL1B and
Figure 2. Reverse phase protein arrays in osteoarthritic and normal cartilage tissues. (A) Differentially expressed proteins between
osteoarthritic and normal chondrocytes. Up-regulated are shown with red color, while down-regulated with green color. (B) Representative western
blot analysis in protein extracts from five osteoarthritic tissues in comparison with normal cartilage. (C) Sub-cellular localization of differentially
expressed proteins. (D) Functional clustering analysis of differentially expressed proteins (using DAVID NIH Bioinformatic Database). (E) Correlation
coefficient wheel between protein expression levels of differentially expressed proteins in osteoarthritic vs normal chondrocytes and body mass
index (BMI). We identified 3 protein groups, which showed statistically significant correlations between protein expression and BMI, according to the
coefficient correlation index (r
2). More specifically, the first group with the highest correlation (r
2.0.900) consisted of PPARA, BMP7, IL1B, LEP (leptin)
and SREBP1 proteins. The second group (0.600.r
2.0.900) consisted of ITGA5, ADIPOQ (adiponectin), FGF23, MMP13, RETN (resistin) and SOX9. The
third group (0.400.r
2.0.600) consisted of 3 proteins (HADHA, ADAMTS5, PPARG) which had low degree of correlation with BMI. The rest of the
proteins were not correlated with BMI.
doi:10.1371/journal.pone.0003740.g002
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understand how IL1B affects not just MMP13 but cartilage
homeostasis pathways, we over-expressed IL1B in normal chondro-
cytes and monitored the expression of the proteins involved in the
cartilage network. IL1B over-expression pertubated the cartilage
homeostasis sub-network by activation of metalloproteinases and
aggrecanases and down-regulation of cartilage structural proteins.
(Figure 4C), connecting thus inflammation and cartilage homeo-
stasis sub-networks with osteoarthritis development.
PPARA and BMP7 regulate IL1B and MMP13 expression in
chondrocytes
In order to delineate the PPARA-IL1B-MMP13 potential
pathway we followed an RNA interference strategy. More
specifically, siRNA inhibition of PPARA increased IL1B (2.5 fold)
and MMP13 (3.5 fold) expression levels (Figure 5A). IL1B was
found to be highly induced 24 h after siRNA PPARA treatment,
while MMP13 was highly induced 48 h after siRNA treatment,
suggesting a sequential activation of MMP13 by IL1B.
The second target of miR-22, BMP7, is frequently down-
regulated in osteoarthritic cartilage, while BMP7 overexpression
induces cartilage formation in vitro and in vivo [31]. It has been
shown that IL1B and ACAN (aggrecan) [32] levels are regulated
by BMP7 in osteoarthritic cartilage. These correlations were
present in the cartilage homeostasis sub-network and in addition
we found that siRNA against BMP7 resulted in increased IL1B
and MMP13 (2 fold) expression in normal chondrocytes
(Figure 5B). Furthermore, we detected high correlation between
BMP7 and ACAN mRNA levels (Figure 5C) and found that
BMP7 siRNA down-regulation blocked effectively ACAN expres-
sion (Figure 5D).
miR-22 blocks MMP13 activity and inhibits cartilage
destruction
Overexpression of miR-22 in normal chondrocytes resulted in
increased IL1B (5.8 fold) and MMP13 (8.1 fold) expression and
decreased aggrecan (4.9 fold) expression (Figure 6A). These
results point towards the implication of the combinatory effect in
Figure 3. Interactome network in osteoarthritis. (A) Construction of an interactome network (p=10-
49) by integrating microRNA and proteomic
data using Ingenuity Pathway Analysis (IPA) (more information in suppl. methods). The p value indicates the likelihood of focus genes to belong to a
network versus those obtained by chance. Around half of the microRNAs (mir-337, miR-29a, miR-22, miR-103-1, miR-25) regulate genes involved in
the metabolic pathways. (B) Correlation coefficients between microRNA expression levels and their gene targets protein levels in osteoarthritic and
normal chondrocytes. (C) Predicted duplex formation between PPARA and BMP7 39UTR with miR-22. (D) BMP7 and PPARA protein levels after miR-22
or inhibitor of miR-22 (as-miR-22) treatment (50 nM) for 48 h in normal and osteoarthritic chondrocytes, respectively.
doi:10.1371/journal.pone.0003740.g003
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22 overexpression through PPARA and BMP7. Additionally,
inhibition of miR-22 in osteoarthritic chondrocytes up-regulated
PPARA (4.9 fold) and BMP7 (5.8 fold) expression, blocked the
inflammatory process, through inhibition of IL1B (7.6 fold),
inhibited catabolic changes such as MMP13 expression (7.9 fold)
and activated the cartilage repair protein aggrecan (3.1 fold)
(Figure 6B), suggesting the therapeutic potential of microRNA
inhibition in osteoarthritis. Furthermore, Western blot, ELISA and
immunofluorescence experiments revealed a high decrease of
MMP13 expression in osteoarthritic chondrocytes after miR-22
inhibition (Figure 6 C–E). MMP13 is one of the major
pathophysiological mediators of cartilage destruction, through
degradation of type II collagen in osteoarthritis [33] and therefore
its down-regulation is of great clinical importance.
Discussion
We detected, for the first time to our knowledge, a 16
microRNA gene signature differentially expressed in osteoarthritis.
The biological significance of microRNAs is determined by their
gene targets which currently can be predicted computationally by
prediction algorithms. In order to have experimental data for
identification of microRNA gene targets, we performed proteomic
analysis, using reverse-phase protein arrays, which revealed a 76
protein signature differentially expressed in osteoarthritis. This
technology platform has been designed for quantitative multi-
plexed analysis of cellular proteins from a limited amount of
sample [34], offering thus a major advantage for protein
quantification levels from tissues such as cartilage, where the
material is frequently limited.
Proteomic analysis was validated by detecting differentially
expressed genes such as GDF5, that have been identified as
osteoarthritis susceptibility genes by gene association studies [3].
Up to date most osteoarthritis molecular studies focus their
interest in cartilage homeostasis mechanisms. However our
global approach identified proteins related with osteoarthritis
pathobiology, that are involved in lipid metabolism and
inflammatory pathways, providing a new source of protein
expression data that need to be explored in greater detail. For
Figure 4. IL1B regulates important components of cartilage homeostasis network. (A) Treatment with IL1B (10 ng/ml) induces MMP-13
mRNA levels assessed by Real-time PCR analysis in normal and osteoarthritic chondrocytes. (B) ELISA assay detecting MMP-13 levels after IL-1b
treatment of osteoarthritic chondrocytes. (C) Pertubation of IL1B affects important gene network components in normal chondrocytes. Treatment of
normal chondrocytes with IL1B (10ng/ml) for 48 h affects the protein expression of cartilage structure related genes (red color shows up-regulation
while green color down-regulation of protein expression). This experiment was performed in quadruplicate. Specifically there is activation of
metalloproteinases 3 and 13 (MMP3, MMP13) and aggrecanases (ADAMTS4, ADAMTS5) leading to down-regulation of the cartilage structural proteins
(ACAN, SPARC, COMP, TPM2, MATN3, COL2A1). In addition asporin (ASPN) is up-regulated which has been shown to inhibit TGF-beta and aggrecan
synthesis (look ref 11). Furthermore SOX9, an important trascription factor implicated in chondrogenesis is highly down-regulated.
doi:10.1371/journal.pone.0003740.g004
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WWOX to be differentially expressed in osteoarthritic cartilage.
Sock et al, have shown that SOX11 is an important transcription
factor related with skeletal malformations [35]. Similarly, recently
Aqeilan et al showed that WWOX -/- mice develop metabolic
bone disease [36]. In addition CCR3 has been found up-
regulated in adipose tissue from obese individuals [37]. All these
studies suggest that these proteins are directly or indirectly
related with osteoarthritis and their differential expression
observed in our study in osteoarthritic chondrocytes supports
the idea that these proteins are involved in cartilage destruction
pathways. However, additional molecular studies are needed to
clarify the role and importance of these proteins in osteoarthritis
development.
Comparison of proteomic and clinical data revealed metabo-
lism-related proteins differentially expressed in osteoarthritic
chondrocytes to be correlated with BMI. It has been described
that mechanoreceptors are activated in knee chondrocytes due to
excess of weight contributing to cartilage destruction. Very
interestingly, our proteomic analysis revealed that ITGA5
mechanoreceptor protein was highly up-regulated in osteoarthritic
chondrocytes and was correlated with BMI. Previous studies have
described integrin-dependent signalling cascades in chondrocyte
mechanotransduction. Furthermore Chowdhury et al., showed an
integrin-mediated mechanotransduction in IL1B-stimulated chon-
drocytes, suggesting the relationship between cartilage structure
and inflammatory pathways [38].
The present work has led to the identification of an
‘‘interactome’’ network involved in the pathogenesis of osteoar-
thritis. We have shown that integration of microRNA, protein
expression and clinical data can be used to generate a network of
potential functional associations with osteoarthritis. We were able
to validate experimentally the interplay between metabolism
genes, inflammatory molecules and cartilage homeostasis enzymes
through microRNA mechanism of action. Specifically we found
regulation of IL1B and MMP13 by PPARA and BMP7 through
miR-22. Consistent with our studies, Watters et al, showed that
PPARA expression is reduced in a STR/Ort osteoarthritis mouse
model [29]. IL1B is a central node in our network and
perturbation of its expression (over-expression) contributes to
cartilage destruction. Our molecular data are consistent with
several clinical studies implicating the role of obesity and
inflammation in cartilage destruction. Several clinical studies have
suggested the effect of obesity in the development of osteoarthritis
Figure 5. PPARA and BMP7 signaling pathways in chondrocytes. (A) Assessment of IL1B and MMP13 mRNA levels after down-regulation of
PPARA, 24 and 48 h after siRNA liposomal treatment into chondrocytes. (B) IL1B and MMP13 expression 24 and 48 h after BMP7 siRNA treatment. (C)
Evaluation and correlation of BMP7 and ACAN (aggrecan) mRNA levels in normal and osteoarthritic chondrocytes assessed by real-time PCR analysis.
(D) Aggrecan expression levels 48 h after BMP7 inhibition of expression using siRNA transferred by liposomes into normal chondrocytes. All
experiments have been performed in triplicate.
doi:10.1371/journal.pone.0003740.g005
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metabolism with osteoarthritis at the molecular level. Specifically,
Lohmander et al., in a large population study revealed that body
mass is a significant risk factor for osteoarthritis leading to
arthroplasty [5]. In addition Marks proposed that a high body
mass is present in most adults with osteoarthritis [39].
Gene network approaches provide new insights for elucidating
the complexity of diseases such as osteoarthritis. Several genes
consist the sub-networks that are interconnected creating large
gene networks. Alterations in gene expression that are able to
perturb a network have a causal relationship with disease [40].
The integration of gene expression profiling and clinical data
provides a detailed picture of how a network state is correlated
with disease and furthermore leads to the development of new
treatments that target the gene network as opposed to current
therapeutic approaches focused on targeting one specific gene
only. This strategy will help to improve the understanding of the
pathogenesis of multifactorial diseases such as osteoarthritis and
provide possible novel therapeutic targets.
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Figure 6. miR-22 regulates PPARA and BMP7 signaling pathways in human chondrocytes. (A) Evaluation by real-time PCR analysis of IL1B,
MMP13 and ACAN mRNA expression levels 48 h after miR-22 (50 nM) liposomal transfection in normal chondrocytes. Real-time PCR analysis has been
performed in triplicate. (B) Assessment of IL1B, MMP13 and ACAN mRNA levels after antisense-miR-22 transfection in osteoarthritic chondrocytes. As-
miR-22 treatment affects very early (24 h) PPARA and BMP7 mRNA expression, while IL1B, MMP13 and ACAN expression is affected later (36–48 h)
suggesting that there are secondary effects. Real-time PCR analysis has been performed in triplicate. (C, D) Western blot analysis and ELISA assay for
MMP13 expression after as-miR-22 overexpression. In ELISA assay each sample has been loaded in quadruplicate and the assay has been performed
in triplicate (average and standard deviation is shown). (E) MMP13 expression evaluated by immunofluorescence analysis of osteoarthritic
chondrocytes after as-miR-22 liposomal transfection. In the bar graph is shown the average of MMP-13 expressing (green fluorescent) cells detected
in 20 different fields in the microscope.
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